| Name | tert-butyl N-(4-bromo-5-formyl-1,3-thiazol-2-yl)carbamate |
|---|---|
| Synonyms | tert-butyl 4-bromo-5-formylthiazol-2-ylcarbamate |
| Molecular Formula | C9H11BrN2O3S |
|---|---|
| Molecular Weight | 307.16400 |
| Exact Mass | 305.96700 |
| PSA | 99.76000 |
| LogP | 2.48700 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934100090 |
|
~64%
944805-17-8 |
| Literature: MERCK SHARP and DOHME CORP.; ADDEX PHARMA S.A.; LIVERTON, Nigel, J.; BOLEA, Christelle; CELANIRE, Sylvain; YUNFU, Luo Patent: WO2012/8999 A2, 2012 ; Location in patent: Page/Page column 56; 57 ; WO 2012/008999 A2 |
|
~60%
944805-17-8 |
| Literature: AMGEN INC. Patent: US2007/173506 A1, 2007 ; Location in patent: Page/Page column 79 ; |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |